Announced on its homepage: “has played pivotal roles in scaling financial operations, raising over $400 million through private and public financings, and leading co…”.
Observed on the company’s website; business claims are not independently verified.
Announced on its homepage: “has played pivotal roles in scaling financial operations, raising over $400 million through private and public financings, and leading co…”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
“Our goal is to modulate key culprits of immunosuppression in the tumour microenvironment to maximize the potential of checkpoint inhibitors." Catherine Pickering, CEO
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen February 2020 · 1 capture · latest observed messagingBuilding on complementary mechanisms between cancer and fibrosis
Our Pipeline iOnctura’s pipeline contains an exquisitely selective PI3Kδ small molecule inhibitor which has just entered a phase I clinical trial in solid tumours, a second generation selective ATX sm
Seen February 2019 · 1 captureiOnctura, modulate key culprits of immunosuppression tumour microenvironment
Our Pipeline We are developing a pipeline of carefully selected assets. Programs in oncology aim to harness both immune-mediated and direct anti-tumour activity to deliver superior clinical efficacy i